Dermatology

Dear Healthcare Professional, Enstilar® is now available with supply resumed. LEO Pharma is actively notifying healthcare professionals to support appropriate patient access to Enstilar®. We sincerely apologise for any inconvenience that this may have caused you and your patients.

Dear Healthcare Professional, Daivonex® Cream is currently experiencing a global shortage due to the lack of availability of one of the excipients in the formulation of the cream. LEO Pharma has submitted an application to the TGA for an alternative overseas calcipotriol only product to be available in Australia during the shortage period, and is awaiting the outcome. For further information about this shortage, please refer to the TGA's Medicines Shortage website: Calcipotriol - TGA Medicines Shortage listing

Daivonex® scalp solution - calcipotriol 50 microgram/mL solution (bottle) - (Please note: this product was delisted from the PBS on 1st September 2012 and the product has been subsequently discontinued in Australia)